CONTTRIBUTE
Alnylam Pharmaceuticals, Inc.
Mark For: CONTTRIBUTE™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88872680 |
| Mark Literal Elements | CONTTRIBUTE |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-08-11 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Ann Lamport Hammitte |
| Attorney Docket Number | A2038-2044 |
Timeline
| 2020-04-15 | Application Filed |
| 2020-04-18 | Location: NEW APPLICATION PROCESSING |
| 2020-04-18 | Status: Live/Pending |
| 2020-04-18 | Transaction Date |
| 2020-06-16 | Published |
| 2020-08-11 | Location: INTENT TO USE SECTION |
| 2020-08-11 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Trademark Parties (Applicants & Owners)
| Party: |  Alnylam Pharmaceuticals, Inc. |
| Address | 300 Third Street, 3rd Floor Cambridge, MASSACHUSETTS UNITED STATES 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | MULTI | 2020-04-15 |
 Drawing | JPEG | 2020-04-15 |
| XSearch Search Summary | APPLICATION/XML | 2020-05-14 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-05-15 |
| Notice of Publication | XML | 2020-05-27 |
| Notification Of Notice of Publication | XML | 2020-05-27 |
| OG Publication Confirmation | APPLICATION/XML | 2020-06-16 |
| Notice of Allowance | XML | 2020-08-11 |
Attorney of Record
Good, Services, and Codes
IC 035. US 100 101 102. G & S: Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| Type Code | Type |
|---|---|
| GS0351 | Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-08-11 | |
| PUBLISHED FOR OPPOSITION | 2020-06-16 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-16 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-05-27 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-14 | |
| ASSIGNED TO EXAMINER | 2020-05-06 | 93063 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-04-23 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-04-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 